Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine Mouthwash for Prevention of Mucositis in HSCT Patients
NCT07325383Phase 3Active, not recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oral mucositis (OM) comparing N-Acetylcysteine group with Placebo group (2 arms). Primary endpoints: Incidence of oral mucositis, Incidence of N-acetylcysteine-related Adverse Events and 1 more. Started Aug 2024; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07325383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07325383.